{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:23:29Z","timestamp":1792167809150,"version":"4.4.0"},"reference-count":78,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T00:00:00Z","timestamp":1726099200000},"content-version":"vor","delay-in-days":42,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008047","name":"Carnegie Mellon University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019779","name":"Qatar National Library","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019779","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.dsx.2024.103118","type":"journal-article","created":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T06:45:09Z","timestamp":1726123509000},"page":"103118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["The effect of microbiome-modulating therapeutics on glucose homeostasis in metabolic syndrome: A systematic review, meta-analysis, and meta-regression of clinical trials"],"prefix":"10.1016","volume":"18","author":[{"given":"Ridhima","family":"Kaul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6283-1596","authenticated-orcid":false,"given":"Pradipta","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3552-5766","authenticated-orcid":false,"given":"Manale","family":"Harfouche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Ayyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sa'ad","family":"Laws","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0171-143X","authenticated-orcid":false,"given":"Ali","family":"Chaari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dsx.2024.103118_bib1","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1177\/1753944717711379","article-title":"Metabolic syndrome: pathophysiology, management, and modulation by natural compounds","volume":"11","author":"Rochlani","year":"2017","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"10.1016\/j.dsx.2024.103118_bib2","doi-asserted-by":"crossref","first-page":"142","DOI":"10.5539\/gjhs.v5n6p142","article-title":"Prevalence of metabolic syndrome in type 2 diabetes mellitus using NCEP-ATPIII, IDF and WHO definition and its agreement in Gwalior Chambal region of Central India","volume":"5","author":"Yadav","year":"2013","journal-title":"Glob J Health Sci"},{"key":"10.1016\/j.dsx.2024.103118_bib3","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehab724.2420","article-title":"Division of clinical pharmacology and therapeutics the university of Hong Kong, Hong Kong D of M. Prevalence of metabolic syndrome in the United States national health and nutrition examination survey (nhanes) 2011\u20132018","volume":"42","author":"Liang","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.dsx.2024.103118_bib4","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1186\/1471-2458-10-529","article-title":"Epidemiological and economic burden of metabolic syndrome and its consequences in patients with hypertension in Germany, Spain and Italy; a prevalence-based model","volume":"10","author":"Scholze","year":"2010","journal-title":"BMC Publ Health"},{"key":"10.1016\/j.dsx.2024.103118_bib5","first-page":"157","article-title":"Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the international diabetes federation diabetes atlas","author":"Saeedi","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.dsx.2024.103118_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/nu12102983","article-title":"Dietary strategies for metabolic syndrome: a comprehensive review","volume":"12","author":"Castro-Barquero","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.dsx.2024.103118_bib7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1017\/S095442241700018X","article-title":"Probiotics, prebiotics, synbiotics and insulin sensitivity","volume":"31","author":"Kim","year":"2018","journal-title":"Nutr Res Rev"},{"key":"10.1016\/j.dsx.2024.103118_bib8","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1097\/CM9.0000000000000696","article-title":"Gut microbiota and metabolic syndrome","volume":"133","author":"Wang","year":"2020","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.dsx.2024.103118_bib9","article-title":"Role of the gut microbiota in nutrition and health","volume":"361","author":"Valdes","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.dsx.2024.103118_bib10","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/00004836-200603000-00015","article-title":"Colonic health: fermentation and short chain fatty acids","volume":"40","author":"Wong","year":"2006","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.dsx.2024.103118_bib11","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/nature25973","article-title":"Environment dominates over host genetics in shaping human gut microbiota","volume":"555","author":"Rothschild","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.dsx.2024.103118_bib12","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/ijo.2017.66","article-title":"Gut microbiome diversity and high-fibre intake are related to lower long-term weight gain","volume":"41","author":"Menni","year":"2017","journal-title":"Int J Obes"},{"key":"10.1016\/j.dsx.2024.103118_bib13","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12944-016-0278-4","article-title":"The role of Gut Microbiota in the development of obesity and Diabetes","volume":"15","author":"Baothman","year":"2016","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.dsx.2024.103118_bib14","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.jhep.2011.02.035","article-title":"DSS induced colitis increases portal LPS levels and enhances hepatic inflammation and fibrogenesis in experimental NASH","volume":"55","author":"G\u00e4bele","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.dsx.2024.103118_bib15","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/nature06244","article-title":"The human microbiome project","volume":"449","author":"Turnbaugh","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.dsx.2024.103118_bib16","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1111\/j.1365-2958.2006.05056.x","article-title":"A microbial world within us","volume":"59","author":"Zoetendal","year":"2006","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.dsx.2024.103118_bib17","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1126\/science.aad3503","article-title":"Population-level analysis of gut microbiome variation","volume":"352","author":"Falony","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.dsx.2024.103118_bib18","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.bbrc.2015.12.083","article-title":"Analysis of the microbiome: advantages of whole genome shotgun versus 16S amplicon sequencing","volume":"469","author":"Ranjan","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.dsx.2024.103118_bib19","doi-asserted-by":"crossref","first-page":"5565","DOI":"10.1021\/acs.analchem.7b00660","article-title":"High throughput and quantitative measurement of microbial metabolome by gas chromatography\/mass spectrometry using automated alkyl chloroformate derivatization","volume":"89","author":"Zhao","year":"2017","journal-title":"Anal Chem"},{"key":"10.1016\/j.dsx.2024.103118_bib20","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s40168-018-0557-6","article-title":"Linking gut microbiota, metabolic syndrome and economic status based on a population-level analysis","volume":"6","author":"He","year":"2018","journal-title":"Microbiome"},{"key":"10.1016\/j.dsx.2024.103118_bib21","doi-asserted-by":"crossref","first-page":"137","DOI":"10.5946\/ce.2019.009","article-title":"Fecal microbiota transplantation: an update on clinical practice","volume":"52","author":"Kim","year":"2019","journal-title":"Clin Endosc"},{"key":"10.1016\/j.dsx.2024.103118_bib22","first-page":"734","volume":"30","author":"Cresci","year":"2015"},{"key":"10.1016\/j.dsx.2024.103118_bib23","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/s41575-020-0344-2","article-title":"The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics","volume":"17","author":"Swanson","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.dsx.2024.103118_bib24","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nrgastro.2017.75","article-title":"Expert consensus document: the International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics","volume":"14","author":"Gibson","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.dsx.2024.103118_bib25","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3390\/toxins14090623","article-title":"Postbiotics and kidney disease","volume":"14","author":"Favero","year":"2022","journal-title":"Toxins"},{"key":"10.1016\/j.dsx.2024.103118_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.906243","article-title":"The promising role of microbiome therapy on biomarkers of inflammation and oxidative stress in type 2 diabetes: a systematic and narrative review","volume":"9","author":"Paul","year":"2022","journal-title":"Front Nutr"},{"key":"10.1016\/j.dsx.2024.103118_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106520","article-title":"The effect of microbiome-modulating probiotics, prebiotics and synbiotics on glucose homeostasis in type 2 diabetes: a systematic review, meta-analysis, and meta-regression of clinical trials","volume":"185","author":"Paul","year":"2022","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.dsx.2024.103118_bib28","article-title":"Microbiome-modulating nutraceuticals ameliorate dyslipidemia in type 2 diabetes: a systematic review, meta-analysis, and meta-regression of clinical trials","author":"Kaul","year":"2023","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.dsx.2024.103118_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232314838","article-title":"Renal health improvement in diabetes through microbiome modulation of the gut\u2013kidney Axis with biotics: a systematic and narrative review of randomized controlled trials","volume":"23","author":"Paul","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.dsx.2024.103118_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.1052619","article-title":"Can probiotic, prebiotic, and synbiotic supplementation modulate the gut-liver axis in type 2 diabetes? A narrative and systematic review of clinical trials","volume":"9","author":"Al-Najjar","year":"2022","journal-title":"Front Nutr"},{"key":"10.1016\/j.dsx.2024.103118_bib31","first-page":"7","article-title":"16.1.3.2 Imputing standard deviations for changes from baseline","author":"Part","year":"2011","journal-title":"Cochrane Handb Syst Rev Interv [Internet]"},{"key":"10.1016\/j.dsx.2024.103118_bib32","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1177\/1932296818805074","article-title":"Insulin units and conversion factors: a story of truth, boots, and faster half-truths","volume":"13","author":"Knopp","year":"2019","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.dsx.2024.103118_bib33","series-title":"RStudio: integrated development environment for R","year":"2019"},{"key":"10.1016\/j.dsx.2024.103118_bib34","first-page":"51","article-title":"Glossary of terms in the Cochrane collaboration version 4.2.5 updated may 2005","author":"Higgins","year":"2005","journal-title":"Cochrane Handb Syst Rev"},{"key":"10.1016\/j.dsx.2024.103118_bib35","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jff.2017.12.041","article-title":"Effect of the consumption of a synbiotic diet mousse containing Lactobacillus acidophilus La-5 by individuals with metabolic syndrome: a randomized controlled trial","volume":"41","author":"Xavier-Santos","year":"2018","journal-title":"J Funct Foods"},{"key":"10.1016\/j.dsx.2024.103118_bib36","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3945\/jn.112.166132","article-title":"A mixture of trans-galactooligosaccharides reduces markers of metabolic syndrome and modulates the fecal microbiota and immune function of overweight adults","volume":"143","author":"Vulevic","year":"2013","journal-title":"J Nutr"},{"key":"10.1016\/j.dsx.2024.103118_bib37","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3168\/jds.2012-5863","article-title":"Short communication: effect of supplementation with Lactobacillus casei Shirota on insulin sensitivity, \u03b2-cell function, and markers of endothelial function and inflammation in subjects with metabolic syndrome--a pilot study","volume":"96","author":"Tripolt","year":"2013","journal-title":"J Dairy Sci"},{"key":"10.1016\/j.dsx.2024.103118_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/nu11081761","article-title":"Lactobacillus reuteri V3401 reduces inflammatory biomarkers and modifies the gastrointestinal microbiome in adults with metabolic syndrome: the PROSIR study","volume":"11","author":"Tenorio-Jim\u00e9nez","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.dsx.2024.103118_bib39","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.008342","article-title":"Effect of vegan fecal microbiota transplantation on carnitine- and choline-derived trimethylamine-N-oxide production and vascular inflammation in patients with metabolic syndrome","volume":"7","author":"Smits","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.dsx.2024.103118_bib40","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s13167-021-00243-4","article-title":"Positive influence of gut microbiota on the effects of Korean red ginseng in metabolic syndrome: a randomized, double-blind, placebo-controlled clinical trial","volume":"12","author":"Seong","year":"2021","journal-title":"EPMA J"},{"key":"10.1016\/j.dsx.2024.103118_bib41","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s00394-016-1369-8","article-title":"Effects of a diet rich in arabinoxylan and resistant starch compared with a diet rich in refined carbohydrates on postprandial metabolism and features of the metabolic syndrome","volume":"57","author":"Schioldan","year":"2018","journal-title":"Eur J Nutr"},{"key":"10.1016\/j.dsx.2024.103118_bib42","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.nut.2018.12.011","article-title":"Effects of probiotic yogurt on glycemic indexes and endothelial dysfunction markers in patients with metabolic syndrome","volume":"62","author":"Rezazadeh","year":"2019","journal-title":"Nutrition"},{"key":"10.1016\/j.dsx.2024.103118_bib43","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1080\/19390211.2018.1455788","article-title":"The effects of synbiotic supplementation on body mass index, metabolic and inflammatory biomarkers, and appetite in patients with metabolic syndrome: a triple-blind randomized controlled trial","volume":"16","author":"Rabiei","year":"2019","journal-title":"J Diet Suppl"},{"key":"10.1016\/j.dsx.2024.103118_bib44","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1136\/bmjmilitary-2020-001459","article-title":"Effects of synbiotic supplementation on the components of metabolic syndrome in military personnel: a double-blind randomised controlled trial","volume":"168","author":"Parastouei","year":"2022","journal-title":"BMJ Mil Heal"},{"key":"10.1016\/j.dsx.2024.103118_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.662159","article-title":"Effect of fecal microbiota transplantation combined with mediterranean diet on insulin sensitivity in subjects with metabolic syndrome","volume":"12","author":"Koopen","year":"2021","journal-title":"Front Microbiol"},{"key":"10.1016\/j.dsx.2024.103118_bib46","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1017\/S0007114514000919","article-title":"Effects of synbiotic supplementation on insulin resistance in subjects with the metabolic syndrome: a randomised, double-blind, placebo-controlled pilot study","volume":"112","author":"Eslamparast","year":"2014","journal-title":"Br J Nutr"},{"key":"10.1016\/j.dsx.2024.103118_bib47","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/s41591-019-0495-2","article-title":"Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study","volume":"25","author":"Depommier","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.dsx.2024.103118_bib48","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s00394-020-02271-8","article-title":"Impact of a short-term synbiotic supplementation on metabolic syndrome and systemic inflammation in elderly patients: a randomized placebo-controlled clinical trial","volume":"60","author":"Cicero","year":"2021","journal-title":"Eur J Nutr"},{"key":"10.1016\/j.dsx.2024.103118_bib49","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1093\/ajcn\/nqy358","article-title":"Yogurt improves insulin resistance and liver fat in obese women with nonalcoholic fatty liver disease and metabolic syndrome: a randomized controlled trial","volume":"109","author":"Chen","year":"2019","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.dsx.2024.103118_bib50","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.nut.2015.11.001","article-title":"Beneficial effects of Bifidobacterium lactis on lipid profile and cytokines in patients with metabolic syndrome: a randomized trial. Effects of probiotics on metabolic syndrome","volume":"32","author":"Bernini","year":"2016","journal-title":"Nutrition"},{"key":"10.1016\/j.dsx.2024.103118_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/nu11092089","article-title":"Effects of regular kefir consumption on gut microbiota in patients with metabolic syndrome: a parallel-group, randomized, controlled study","volume":"11","author":"Bellikci-Koyu","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.dsx.2024.103118_bib52","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.nut.2013.12.004","article-title":"Beneficial effects of Lactobacillus plantarum on glycemia and homocysteine levels in postmenopausal women with metabolic syndrome","volume":"30","author":"Barreto","year":"2014","journal-title":"Nutrition"},{"key":"10.1016\/j.dsx.2024.103118_bib53","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.cmet.2017.09.008","article-title":"Improvement of insulin sensitivity after lean donor feces in metabolic syndrome is driven by baseline intestinal microbiota composition","volume":"26","author":"Kootte","year":"2017","journal-title":"Cell Metab"},{"key":"10.1016\/j.dsx.2024.103118_bib54","series-title":"Gut-microbial metabolites, probiotics and their roles in type 2 diabetes","author":"Zhai","year":"2021"},{"key":"10.1016\/j.dsx.2024.103118_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13098-020-00603-6","article-title":"Probiotics supplementation and insulin resistance: a systematic review","volume":"12","author":"Salles","year":"2020","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/j.dsx.2024.103118_bib56","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1093\/advances\/nmaa133","article-title":"Probiotics contribute to glycemic control in patients with type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"12","author":"Rittiphairoj","year":"2021","journal-title":"Adv Nutr"},{"key":"10.1016\/j.dsx.2024.103118_bib57","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.770861","article-title":"Effects of probiotic supplementation on inflammatory markers and glucose homeostasis in adults with type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"12","author":"Ding","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.dsx.2024.103118_bib58","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s41999-020-00396-x","article-title":"Can probiotics, prebiotics and synbiotics improve functional outcomes for older people: a systematic review","volume":"11","author":"Coutts","year":"2020","journal-title":"Eur Geriatr Med"},{"key":"10.1016\/j.dsx.2024.103118_bib59","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.clnu.2021.11.037","article-title":"Meta-analysis of randomized controlled trials of the effects of probiotics on type 2 diabetes in adults","volume":"41","author":"Zhang","year":"2022","journal-title":"Clin Nutr"},{"key":"10.1016\/j.dsx.2024.103118_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0255446","article-title":"Characteristics of gut microbiota in people with obesity","volume":"16","author":"Duan","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.dsx.2024.103118_bib61","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s13679-020-00379-w","article-title":"Probiotics, prebiotics, synbiotics, postbiotics, and obesity: current evidence, controversies, and perspectives","volume":"9","author":"Vallianou","year":"2020","journal-title":"Curr Obes Rep"},{"key":"10.1016\/j.dsx.2024.103118_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/microorganisms8081148","article-title":"Probiotics for the treatment of overweight and obesity in humans\u2014a review of clinical trials","volume":"8","author":"Wici\u0144ski","year":"2020","journal-title":"Microorganisms"},{"key":"10.1016\/j.dsx.2024.103118_bib63","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1007\/s00394-016-1199-8","article-title":"Effect of multi-strain probiotics (multi-strain microbial cell preparation) on glycemic control and other diabetes-related outcomes in people with type 2 diabetes: a randomized controlled trial","volume":"56","author":"Firouzi","year":"2017","journal-title":"Eur J Nutr"},{"key":"10.1016\/j.dsx.2024.103118_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13098-018-0353-2","article-title":"The effects of probiotic supplementation on metabolic status in type 2 diabetic patients with coronary heart disease IRCT2017082733941N5 IRCT","volume":"10","author":"Raygan","year":"2018","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/j.dsx.2024.103118_bib65","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.kint.2016.09.040","article-title":"Probiotic supplementation in diabetic hemodialysis patients has beneficial metabolic effects","volume":"91","author":"Soleimani","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.dsx.2024.103118_bib66","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s40200-019-00474-3","article-title":"Effects of probiotic, cinnamon, and synbiotic supplementation on glycemic control and antioxidant status in people with type 2 diabetes; a randomized, double-blind, placebo-controlled study","volume":"19","author":"Mirmiranpour","year":"2020","journal-title":"J Diabetes Metab Disord"},{"key":"10.1016\/j.dsx.2024.103118_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106288","article-title":"Beneficial effects of probiotic and synbiotic supplementation on some cardiovascular risk factors among individuals with prediabetes and type 2 diabetes mellitus: a grade-assessed systematic review, meta-analysis, and meta-regression of randomized clinica","volume":"182","author":"Naseri","year":"2022","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.dsx.2024.103118_bib68","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1093\/cvr\/cvac128","article-title":"The effect of probiotic and synbiotic supplementation on lipid parameters among patients with cardiometabolic risk factors: a systematic review and meta-analysis of clinical trials","volume":"119","author":"Ghorbani","year":"2023","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.dsx.2024.103118_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106061","article-title":"Impact of synbiotic supplementation on cardiometabolic and anthropometric indices in patients with metabolic syndrome: a systematic review and meta-analysis of randomized controlled trials","volume":"176","author":"Arabi","year":"2022","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.dsx.2024.103118_bib70","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2021.775216","article-title":"A meta-analysis of microbial therapy against metabolic syndrome: evidence from randomized controlled trials","volume":"8","author":"Pan","year":"2021","journal-title":"Front Nutr"},{"key":"10.1016\/j.dsx.2024.103118_bib71","doi-asserted-by":"crossref","DOI":"10.1038\/nutd.2013.24","article-title":"Evidence for metabolic endotoxemia in obese and diabetic Gambian women","volume":"3","author":"Hawkesworth","year":"2013","journal-title":"Nutr Diabetes"},{"key":"10.1016\/j.dsx.2024.103118_bib72","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.molmet.2016.06.002","article-title":"Causality of small and large intestinal microbiota in weight regulation and insulin resistance","volume":"5","author":"Scheithauer","year":"2016","journal-title":"Mol Metab"},{"key":"10.1016\/j.dsx.2024.103118_bib73","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.2337\/db06-1491","article-title":"Metabolic endotoxemia initiates obesity and insulin resistance","volume":"56","author":"Cani","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.dsx.2024.103118_bib74","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/srep00799","article-title":"Obesity-induced endoplasmic reticulum stress causes chronic inflammation in adipose tissue","volume":"2","author":"Kawasaki","year":"2012","journal-title":"Sci Rep"},{"key":"10.1016\/j.dsx.2024.103118_bib75","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.cell.2016.10.043","article-title":"A dietary fiber-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility","volume":"167","author":"Desai","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.dsx.2024.103118_bib76","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jfda.2018.12.011","article-title":"Next generation probiotics in disease amelioration","volume":"27","author":"Chang","year":"2019","journal-title":"J Food Drug Anal"},{"key":"10.1016\/j.dsx.2024.103118_bib77","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.cmet.2018.07.001","article-title":"Impaired aryl hydrocarbon receptor ligand production by the gut microbiota is a key factor in metabolic syndrome","volume":"28","author":"Natividad","year":"2018","journal-title":"Cell Metab"},{"key":"10.1016\/j.dsx.2024.103118_bib78","article-title":"remo","volume":"13","author":"Li","year":"2021","journal-title":"Nutrients"}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402124001796?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402124001796?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T07:29:35Z","timestamp":1731310175000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402124001796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":78,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S1871402124001796"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2024.103118","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of microbiome-modulating therapeutics on glucose homeostasis in metabolic syndrome: A systematic review, meta-analysis, and meta-regression of clinical trials","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2024.103118","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Research Trust of DiabetesIndia (DiabetesIndia) and National Diabetes Obesity and Cholesterol Foundation (N-DOC). Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103118"}}